{"transactions":[{"id":901650,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":66261,"kind":"person","name":"McCracken Joseph S","position":1,"cik":"0001632454","reported_name":"McCracken Joseph S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-02-17T22:30:13.000Z","date":"2026-02-16","kind":"exercise","planned":false,"acquired":false,"shares":1807,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vested and became exercisable in twelve equal quarterly installments beginning on March 15, 2017."}],"balance_after":0,"derivative":{"exercise_price":1.76,"expiration_date":"2026-12-15","underlying":"Common Stock","underlying_shares":1807},"source":{"system":"sec-edgar","filing":"0001193125-26-055175","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000119312526055175/ownership.xml","form_type":"4"}},{"id":901649,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":66261,"kind":"person","name":"McCracken Joseph S","position":1,"cik":"0001632454","reported_name":"McCracken Joseph S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-17T22:30:13.000Z","date":"2026-02-16","kind":"exercise","planned":false,"acquired":true,"shares":1807,"price":1.76,"value":3180.32,"ownership":{"direct":true},"balance_after":302644,"source":{"system":"sec-edgar","filing":"0001193125-26-055175","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000119312526055175/ownership.xml","form_type":"4"}},{"id":972923,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":66261,"kind":"person","name":"McCracken Joseph S","position":1,"cik":"0001632454","reported_name":"McCracken Joseph S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-11T22:45:11.000Z","date":"2025-12-09","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") that vest in full on December 9, 2026, subject to the reporting person's continued service with the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The reporting person has elected to defer receipt of the shares of common stock underlying the RSUs upon vesting. In accordance with the reporting person's deferral election, the vested shares will be delivered to the reporting person following the reporting person's termination of service with the Issuer."}],"balance_after":300837,"source":{"system":"sec-edgar","filing":"0001193125-25-316296","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000119312525316296/ownership.xml","form_type":"4"}},{"id":1128003,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":66261,"kind":"person","name":"McCracken Joseph S","position":1,"cik":"0001632454","reported_name":"McCracken Joseph S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-02T11:59:29.000Z","date":"2025-05-29","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":2.0825,"value":20825.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price is a weighted average purchase price. The purchase prices ranged from $2.08 to $2.085. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4."}],"balance_after":260837,"source":{"system":"sec-edgar","filing":"0000950170-25-080021","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000095017025080021/ownership.xml","form_type":"4"}},{"id":1331156,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":66261,"kind":"person","name":"McCracken Joseph S","position":1,"cik":"0001632454","reported_name":"McCracken Joseph S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-16T22:44:39.000Z","date":"2024-12-12","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") that vest in full on December 12, 2025, subject to the reporting person's continued service with the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The reporting person has elected to defer receipt of the shares of common stock underlying the RSUs upon vesting. In accordance with the reporting person's deferral election, the vested shares will be delivered to the reporting person following the reporting person's termination of service with the Issuer."}],"balance_after":250837,"source":{"system":"sec-edgar","filing":"0000950170-24-136770","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000095017024136770/ownership.xml","form_type":"4"}},{"id":1332825,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":66261,"kind":"person","name":"McCracken Joseph S","position":1,"cik":"0001632454","reported_name":"McCracken Joseph S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-13T21:30:38.000Z","date":"2024-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2910,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents an out-of-money option that was cancelled without any cash payment or issuance of CVRs being made in respect thereof pursuant to the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents an out-of-money option that was cancelled without any cash payment or issuance of CVRs being made in respect thereof pursuant to the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":10.36,"expiration_date":"2031-05-19","underlying":"Common Stock","underlying_shares":2910},"source":{"system":"sec-edgar","filing":"0001126234-24-000111","document":"wk-form4_1734143432.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623424000111/wk-form4_1734143432.xml","form_type":"4"}},{"id":1332824,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":66261,"kind":"person","name":"McCracken Joseph S","position":1,"cik":"0001632454","reported_name":"McCracken Joseph S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-13T21:30:38.000Z","date":"2024-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3431,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents an out-of-money option that was cancelled without any cash payment or issuance of CVRs being made in respect thereof pursuant to the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents an out-of-money option that was cancelled without any cash payment or issuance of CVRs being made in respect thereof pursuant to the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":8.18,"expiration_date":"2032-05-04","underlying":"Common Stock","underlying_shares":3431},"source":{"system":"sec-edgar","filing":"0001126234-24-000111","document":"wk-form4_1734143432.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623424000111/wk-form4_1734143432.xml","form_type":"4"}},{"id":1332823,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":66261,"kind":"person","name":"McCracken Joseph S","position":1,"cik":"0001632454","reported_name":"McCracken Joseph S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-13T21:30:38.000Z","date":"2024-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":5684,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents an out-of-money option that was cancelled without any cash payment or issuance of CVRs being made in respect thereof pursuant to the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents an out-of-money option that was cancelled without any cash payment or issuance of CVRs being made in respect thereof pursuant to the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":7.78,"expiration_date":"2030-04-02","underlying":"Common Stock","underlying_shares":5684},"source":{"system":"sec-edgar","filing":"0001126234-24-000111","document":"wk-form4_1734143432.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623424000111/wk-form4_1734143432.xml","form_type":"4"}},{"id":1332822,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":66261,"kind":"person","name":"McCracken Joseph S","position":1,"cik":"0001632454","reported_name":"McCracken Joseph S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-13T21:30:38.000Z","date":"2024-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3328,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This option was cancelled pursuant to the Merger Agreement in exchange for (i) an amount in cash equal to the product of (x) the total number of shares underlying such option multiplied by (y) the excess of the Cash Amount over the applicable exercise price per share and (ii) one CVR for each share underlying such in-the-money option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was cancelled pursuant to the Merger Agreement in exchange for (i) an amount in cash equal to the product of (x) the total number of shares underlying such option multiplied by (y) the excess of the Cash Amount over the applicable exercise price per share and (ii) one CVR for each share underlying such in-the-money option."}],"balance_after":0,"derivative":{"exercise_price":2.35,"expiration_date":"2034-06-04","underlying":"Common Stock","underlying_shares":3328},"source":{"system":"sec-edgar","filing":"0001126234-24-000111","document":"wk-form4_1734143432.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623424000111/wk-form4_1734143432.xml","form_type":"4"}},{"id":1332821,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":66261,"kind":"person","name":"McCracken Joseph S","position":1,"cik":"0001632454","reported_name":"McCracken Joseph S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-13T21:30:38.000Z","date":"2024-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3345,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This option was cancelled pursuant to the Merger Agreement in exchange for (i) an amount in cash equal to the product of (x) the total number of shares underlying such option multiplied by (y) the excess of the Cash Amount over the applicable exercise price per share and (ii) one CVR for each share underlying such in-the-money option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was cancelled pursuant to the Merger Agreement in exchange for (i) an amount in cash equal to the product of (x) the total number of shares underlying such option multiplied by (y) the excess of the Cash Amount over the applicable exercise price per share and (ii) one CVR for each share underlying such in-the-money option."}],"balance_after":0,"derivative":{"exercise_price":3.42,"expiration_date":"2033-05-09","underlying":"Common Stock","underlying_shares":3345},"source":{"system":"sec-edgar","filing":"0001126234-24-000111","document":"wk-form4_1734143432.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623424000111/wk-form4_1734143432.xml","form_type":"4"}},{"id":1332820,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":66261,"kind":"person","name":"McCracken Joseph S","position":1,"cik":"0001632454","reported_name":"McCracken Joseph S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-13T21:30:38.000Z","date":"2024-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":15721,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed of pursuant to that certain Agreement and Plan of Merger, dated October 22, 2024, by and between the Issuer, DPV Parent, Inc., DPV MergerSub, Inc. and Double Point Ventures LLC (\"DPV\") (the \"Merger Agreement\") in exchange for (i) $4.25 in cash per share (the \"Cash Amount\"), plus (ii) one non-transferable contingent value right (\"CVR\") per share."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001126234-24-000111","document":"wk-form4_1734143432.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623424000111/wk-form4_1734143432.xml","form_type":"4"}},{"id":1357592,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":66261,"kind":"person","name":"McCracken Joseph S","position":1,"cik":"0001632454","reported_name":"McCracken Joseph S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-20T12:55:46.000Z","date":"2024-11-19","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":2.9536,"value":59072.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price is a weighted average purchase price. The purchase prices ranged from $2.9481 to $2.9678. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4."}],"balance_after":210837,"source":{"system":"sec-edgar","filing":"0000950170-24-129007","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000095017024129007/ownership.xml","form_type":"4"}},{"id":1487324,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":66261,"kind":"person","name":"McCracken Joseph S","position":1,"cik":"0001632454","reported_name":"McCracken Joseph S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-07T16:07:51.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":3328,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant to the Reporting Person of a nonstatutory stock option under the Issuer's 2009 Equity Incentive Plan (the \"Plan\"). One hundred percent (100%) of the shares shall vest on the earlier of (i) the first anniversary of the date of grant and (ii) the date of the first Annual Meeting following the date of grant, in each case subject to the Reporting Person's continuous service as of such date. The option expires ten years after the date of grant."}],"balance_after":3328,"derivative":{"exercise_price":2.35,"expiration_date":"2034-06-04","underlying":"Common Stock","underlying_shares":3328},"source":{"system":"sec-edgar","filing":"0001126234-24-000077","document":"wk-form4_1717790861.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623424000077/wk-form4_1717790861.xml","form_type":"4"}},{"id":1709645,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":66261,"kind":"person","name":"McCracken Joseph S","position":1,"cik":"0001632454","reported_name":"McCracken Joseph S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-15T22:28:23.000Z","date":"2023-12-14","kind":"grant","planned":false,"acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") that vest in full on December 14, 2024, subject to the reporting person's continued service with the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":190837,"source":{"system":"sec-edgar","filing":"0001209191-23-058841","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000120919123058841/doc4.xml","form_type":"4"}},{"id":1895389,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":66261,"kind":"person","name":"McCracken Joseph S","position":1,"cik":"0001632454","reported_name":"McCracken Joseph S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-12T17:44:35.000Z","date":"2023-05-10","kind":"grant","planned":false,"acquired":true,"shares":3345,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant to the Reporting Person of a nonstatutory stock option under the Issuer's 2009 Equity Incentive Plan (the \"Plan\"). One hundred percent (100%) of the shares shall vest on the earlier of (i) the first anniversary of the date of grant and (ii) the date of the first Annual Meeting following the date of grant, in each case subject to the Reporting Person's continuous service as of such date. The option expires ten years after the date of grant."}],"balance_after":3345,"derivative":{"exercise_price":3.42,"expiration_date":"2033-05-09","underlying":"Common Stock","underlying_shares":3345},"source":{"system":"sec-edgar","filing":"0001126234-23-000071","document":"wf-form4_168392786065137.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623423000071/wf-form4_168392786065137.xml","form_type":"4"}},{"id":2085373,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":66261,"kind":"person","name":"McCracken Joseph S","position":1,"cik":"0001632454","reported_name":"McCracken Joseph S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-15T21:12:25.000Z","date":"2022-12-13","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest and become exercisable on December 13, 2023."}],"balance_after":40000,"derivative":{"exercise_price":1.51,"expiration_date":"2032-12-13","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-22-061424","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000120919122061424/doc4.xml","form_type":"4"}},{"id":2110601,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":66261,"kind":"person","name":"McCracken Joseph S","position":1,"cik":"0001632454","reported_name":"McCracken Joseph S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-18T16:31:44.000Z","date":"2022-11-16","kind":"purchase","acquired":true,"shares":4000,"price":5.03,"value":20120.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were purchased in multiple transactions at prices ranging from $5.005 to $5.0536, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the ranges set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 237 restricted stock units (\"RSUs\") previously reported as holdings of the Reporting Person granted under the Issuer's 2009 Equity Incentive Plan (the \"Plan\").  The RSUs will vest, and shares will be delivered to the Reporting Person in a single installment on April 3, 2023, provided that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan."}],"balance_after":15721,"source":{"system":"sec-edgar","filing":"0001126234-22-000114","document":"wf-form4_166880708979109.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623422000114/wf-form4_166880708979109.xml","form_type":"4"}},{"id":2173126,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":66261,"kind":"person","name":"McCracken Joseph S","position":1,"cik":"0001632454","reported_name":"McCracken Joseph S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-26T16:59:40.000Z","date":"2022-08-25","kind":"purchase","acquired":true,"shares":3170,"price":8.6,"value":27262.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were purchased in multiple transactions at prices ranging from $8.52 to $8.85, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the ranges set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 237 restricted stock units (\"RSUs\") previously reported as holdings of the Reporting Person granted under the Issuer's 2009 Equity Incentive Plan (the \"Plan\").  The RSUs will vest, and shares will be delivered to the Reporting Person in a single installment on April 3, 2023, provided that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan."}],"balance_after":11721,"source":{"system":"sec-edgar","filing":"0001126234-22-000092","document":"wf-form4_166154755894555.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623422000092/wf-form4_166154755894555.xml","form_type":"4"}},{"id":2278088,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":66261,"kind":"person","name":"McCracken Joseph S","position":1,"cik":"0001632454","reported_name":"McCracken Joseph S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-09T17:09:54.000Z","date":"2022-05-05","kind":"grant","acquired":true,"shares":3431,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant to the Reporting Person of a nonstatutory stock option under the Issuer's 2009 Equity Incentive Plan (the \"Plan\"). One hundred percent (100%) of the shares shall vest on the earlier of (i) the first anniversary of the date of grant and (ii) the date of the first Annual Meeting following the date of grant, in each case subject to the Reporting Person's continuous service as of such date. The option expires ten years after the date of grant."}],"balance_after":3431,"derivative":{"exercise_price":8.18,"expiration_date":"2032-05-04","underlying":"Common Stock","underlying_shares":3431},"source":{"system":"sec-edgar","filing":"0001126234-22-000055","document":"wf-form4_165213058031730.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623422000055/wf-form4_165213058031730.xml","form_type":"4"}},{"id":2473847,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":66261,"kind":"person","name":"McCracken Joseph S","position":1,"cik":"0001632454","reported_name":"McCracken Joseph S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-12-14T23:29:35.000Z","date":"2021-12-14","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest and become exercisable on December 14, 2022."}],"balance_after":40000,"derivative":{"exercise_price":1.11,"expiration_date":"2031-12-14","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-21-069585","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000120919121069585/doc4.xml","form_type":"4"}},{"id":2586599,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":66261,"kind":"person","name":"McCracken Joseph S","position":1,"cik":"0001632454","reported_name":"McCracken Joseph S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-08-30T14:55:59.000Z","date":"2021-08-27","kind":"disposition_to_issuer","acquired":false,"shares":48500,"price":4.81,"value":233285.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This option provided for vesting in four equal quarterly installments from the option grant date. Pursuant to the Merger Agreement, the unvested portion of this option was subject to acceleration of vesting. This option was cancelled pursuant to the Merger Agreement in exchange for a cash payment of $233,285.00, representing the difference between the per share exercise price of the option and the merger consideration of $9.25 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option provided for vesting in four equal quarterly installments from the option grant date. Pursuant to the Merger Agreement, the unvested portion of this option was subject to acceleration of vesting. This option was cancelled pursuant to the Merger Agreement in exchange for a cash payment of $233,285.00, representing the difference between the per share exercise price of the option and the merger consideration of $9.25 per share."}],"balance_after":0,"derivative":{"exercise_price":4.44,"expiration_date":"2031-01-19","underlying":"Common Stock","underlying_shares":48500},"source":{"system":"sec-edgar","filing":"0001250853-21-000085","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1632454/000125085321000085/primary_doc.xml","form_type":"4"}},{"id":2586598,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":66261,"kind":"person","name":"McCracken Joseph S","position":1,"cik":"0001632454","reported_name":"McCracken Joseph S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-08-30T14:55:59.000Z","date":"2021-08-27","kind":"disposition_to_issuer","acquired":false,"shares":48500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This option provided for vesting in four equal quarterly installments from the option grant date. This option was cancelled pursuant to the Merger Agreement in exchange for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option provided for vesting in four equal quarterly installments from the option grant date. This option was cancelled pursuant to the Merger Agreement in exchange for no consideration."}],"balance_after":0,"derivative":{"exercise_price":9.84,"expiration_date":"2030-01-16","underlying":"Common Stock","underlying_shares":48500},"source":{"system":"sec-edgar","filing":"0001250853-21-000085","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1632454/000125085321000085/primary_doc.xml","form_type":"4"}},{"id":2586597,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":66261,"kind":"person","name":"McCracken Joseph S","position":1,"cik":"0001632454","reported_name":"McCracken Joseph S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-08-30T14:55:59.000Z","date":"2021-08-27","kind":"disposition_to_issuer","acquired":false,"shares":48500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This option provided for vesting in four equal quarterly installments from the option grant date. This option was cancelled pursuant to the Merger Agreement in exchange for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option provided for vesting in four equal quarterly installments from the option grant date. This option was cancelled pursuant to the Merger Agreement in exchange for no consideration."}],"balance_after":0,"derivative":{"exercise_price":9.91,"expiration_date":"2029-01-31","underlying":"Common Stock","underlying_shares":48500},"source":{"system":"sec-edgar","filing":"0001250853-21-000085","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1632454/000125085321000085/primary_doc.xml","form_type":"4"}},{"id":2586596,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":66261,"kind":"person","name":"McCracken Joseph S","position":1,"cik":"0001632454","reported_name":"McCracken Joseph S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-08-30T14:55:59.000Z","date":"2021-08-27","kind":"disposition_to_issuer","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This option provided for vesting in four equal quarterly installments from the option grant date. This option was cancelled pursuant to the Merger Agreement in exchange for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option provided for vesting in four equal quarterly installments from the option grant date. This option was cancelled pursuant to the Merger Agreement in exchange for no consideration."}],"balance_after":0,"derivative":{"exercise_price":11,"expiration_date":"2028-06-21","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001250853-21-000085","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1632454/000125085321000085/primary_doc.xml","form_type":"4"}},{"id":2586595,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":66261,"kind":"person","name":"McCracken Joseph S","position":1,"cik":"0001632454","reported_name":"McCracken Joseph S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-08-30T14:55:59.000Z","date":"2021-08-27","kind":"disposition_to_issuer","acquired":false,"shares":41890,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This option provided for vesting in four equal quarterly installments from the option grant date. This option was cancelled pursuant to the agreement and plan of merger, dated as of June 15, 2021, by and among the Elanco Animal Health Incorporated, Knight Merger Sub, Inc., and Kindred Biosciences, Inc. (the \"Merger Agreement\") in exchange for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option provided for vesting in four equal quarterly installments from the option grant date. This option was cancelled pursuant to the agreement and plan of merger, dated as of June 15, 2021, by and among the Elanco Animal Health Incorporated, Knight Merger Sub, Inc., and Kindred Biosciences, Inc. (the \"Merger Agreement\") in exchange for no consideration."}],"balance_after":0,"derivative":{"exercise_price":9.65,"expiration_date":"2028-04-19","underlying":"Common Stock","underlying_shares":41890},"source":{"system":"sec-edgar","filing":"0001250853-21-000085","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1632454/000125085321000085/primary_doc.xml","form_type":"4"}},{"id":2604052,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":66261,"kind":"person","name":"McCracken Joseph S","position":1,"cik":"0001632454","reported_name":"McCracken Joseph S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-13T16:31:54.000Z","date":"2021-08-11","kind":"purchase","acquired":true,"shares":7475,"price":7.546,"value":56406.35,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were purchased in multiple transactions at prices ranging from $7.475 to $7.58, inclusive.  The Reporting Person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the ranges set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 473 restricted stock units (\"RSUs\") previously reported as holdings of the Reporting Person granted under the Issuer's 2010 Non-Employee Directors' Stock Award Plan (the \"Plan\").  The RSUs will vest, and shares will be delivered to the Reporting Person in a series of two successive annual installments with the next installment occurring on April 3, 2022, in each case subject to the Reporting Person's continuous service as of such date."}],"balance_after":8551,"source":{"system":"sec-edgar","filing":"0001126234-21-000112","document":"wf-form4_162888669898993.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623421000112/wf-form4_162888669898993.xml","form_type":"4"}},{"id":2699375,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":66261,"kind":"person","name":"McCracken Joseph S","position":1,"cik":"0001632454","reported_name":"McCracken Joseph S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-24T18:36:36.000Z","date":"2021-05-20","kind":"grant","acquired":true,"shares":2910,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Grant to the Reporting Person of a nonstatutory stock option under the Plan. One hundred percent (100%) of the shares shall vest on the earlier of (i) the first anniversary of the date of grant and (ii) the date of the first Annual Meeting following the date of grant, in each case subject to the Reporting Person's continuous service as of such date. The option expires ten years after the date of grant."}],"balance_after":2910,"derivative":{"exercise_price":10.36,"expiration_date":"2031-05-19","underlying":"Common Stock","underlying_shares":2910},"source":{"system":"sec-edgar","filing":"0001126234-21-000081","document":"wf-form4_162189577929307.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623421000081/wf-form4_162189577929307.xml","form_type":"4"}},{"id":2699374,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":66261,"kind":"person","name":"McCracken Joseph S","position":1,"cik":"0001632454","reported_name":"McCracken Joseph S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-24T18:36:36.000Z","date":"2021-05-20","kind":"grant","acquired":true,"shares":367,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares issued as restricted stock units (\"RSUs\") under the Issuer's 2010 Non-Employee Director Stock Award Plan (the \"Plan\") that were received as an award, for no consideration.  The RSUs vest in a single installment on the earlier of (i) the first anniversary of the date of grant and (ii) the date of the first Annual Meeting following the date of grant, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 473 RSUs previously reported as holdings of the Reporting Person granted under the Plan.  The RSUs will vest, and shares will be delivered to the Reporting Person in a series of two successive annual installments with the next installment occurring on April 3, 2022, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan."}],"balance_after":1076,"source":{"system":"sec-edgar","filing":"0001126234-21-000081","document":"wf-form4_162189577929307.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623421000081/wf-form4_162189577929307.xml","form_type":"4"}},{"id":2789511,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":66261,"kind":"person","name":"McCracken Joseph S","position":1,"cik":"0001632454","reported_name":"McCracken Joseph S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-15T18:46:33.000Z","date":"2021-03-15","kind":"purchase","acquired":true,"shares":68965,"price":1.45,"value":99999.25,"ownership":{"direct":true},"balance_after":168337,"source":{"system":"sec-edgar","filing":"0001209191-21-020415","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000120919121020415/doc4.xml","form_type":"4"}},{"id":2899282,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":66261,"kind":"person","name":"McCracken Joseph S","position":1,"cik":"0001632454","reported_name":"McCracken Joseph S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-01-22T17:10:09.000Z","date":"2021-01-20","kind":"grant","acquired":true,"shares":48500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in four equal quarterly installments from the option grant date."}],"balance_after":48500,"derivative":{"exercise_price":4.44,"expiration_date":"2031-01-19","underlying":"Common Stock","underlying_shares":48500},"source":{"system":"sec-edgar","filing":"0001250853-21-000019","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1632454/000125085321000019/primary_doc.xml","form_type":"4"}},{"id":2940501,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":66261,"kind":"person","name":"McCracken Joseph S","position":1,"cik":"0001632454","reported_name":"McCracken Joseph S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-17T17:31:10.000Z","date":"2020-12-16","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest and become exercisable on December 16, 2021."}],"balance_after":40000,"derivative":{"exercise_price":1.23,"expiration_date":"2030-12-16","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-20-063978","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000120919120063978/doc4.xml","form_type":"4"}},{"id":3180851,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":66261,"kind":"person","name":"McCracken Joseph S","position":1,"cik":"0001632454","reported_name":"McCracken Joseph S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-04-07T17:58:20.000Z","date":"2020-04-03","kind":"grant","acquired":true,"shares":5684,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Grant to the Reporting Person of a nonstatutory stock option under the Plan.  One-third of the shares vest on the one-year anniversary of the grant date and the remaining two-thirds of the shares vest in a series of 24 successive equal monthly installments thereafter, subject to the Reporting Persons's continuous service as of such dates.  The option expires ten years after the date of grant, unless it expires sooner pursuant to the terms of the Plan."}],"balance_after":5684,"derivative":{"exercise_price":7.78,"expiration_date":"2030-04-02","underlying":"Common Stock","underlying_shares":5684},"source":{"system":"sec-edgar","filing":"0001126234-20-000062","document":"wf-form4_158629668273144.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623420000062/wf-form4_158629668273144.xml","form_type":"4"}},{"id":3180850,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":66261,"kind":"person","name":"McCracken Joseph S","position":1,"cik":"0001632454","reported_name":"McCracken Joseph S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-07T17:58:20.000Z","date":"2020-04-03","kind":"grant","acquired":true,"shares":709,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares issued as restricted stock units (\"RSUs\") under the Issuer's 2010 Non-Employee Director Stock Award Plan (the \"Plan\") that were received as an award, for no consideration.  The RSUs vest in a series of three successive annual installments beginning on April 3, 2021, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan."}],"balance_after":709,"source":{"system":"sec-edgar","filing":"0001126234-20-000062","document":"wf-form4_158629668273144.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623420000062/wf-form4_158629668273144.xml","form_type":"4"}},{"id":3305307,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":66261,"kind":"person","name":"McCracken Joseph S","position":1,"cik":"0001632454","reported_name":"McCracken Joseph S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-01-22T20:54:51.000Z","date":"2020-01-17","kind":"grant","acquired":true,"shares":48500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in four equal quarterly installments from the option grant date."}],"balance_after":48500,"derivative":{"exercise_price":9.84,"expiration_date":"2030-01-16","underlying":"Common Stock","underlying_shares":48500},"source":{"system":"sec-edgar","filing":"0001250853-20-000032","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1632454/000125085320000032/primary_doc.xml","form_type":"4"}},{"id":3331444,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":66261,"kind":"person","name":"McCracken Joseph S","position":1,"cik":"0001632454","reported_name":"McCracken Joseph S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-12-26T23:00:17.000Z","date":"2019-12-20","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest and become exercisable in twelve equal installments on each quarterly anniversary of December 20, 2019, subject to the reporting person's continued service with the Issuer"}],"balance_after":12000,"derivative":{"exercise_price":1.59,"expiration_date":"2029-12-20","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0000899243-19-030067","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000089924319030067/doc4.xml","form_type":"4"}},{"id":3466372,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":66261,"kind":"person","name":"McCracken Joseph S","position":1,"cik":"0001632454","reported_name":"McCracken Joseph S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-07-08T20:05:19.000Z","date":"2019-07-05","kind":"exercise","acquired":false,"shares":9034,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option vest and become exercisable in twelve equal quarterly installments beginning on March 15, 2017."}],"balance_after":1807,"derivative":{"exercise_price":1.76,"expiration_date":"2026-12-15","underlying":"Common Stock","underlying_shares":9034},"source":{"system":"sec-edgar","filing":"0000899243-19-019303","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000089924319019303/doc4.xml","form_type":"4"}},{"id":3466371,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":66261,"kind":"person","name":"McCracken Joseph S","position":1,"cik":"0001632454","reported_name":"McCracken Joseph S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-07-08T20:05:19.000Z","date":"2019-07-05","kind":"exercise","acquired":false,"shares":5860,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option vested and became exercisable in twelve equal quarterly installments beginning on March 15, 2016."}],"balance_after":0,"derivative":{"exercise_price":1.46,"expiration_date":"2025-12-15","underlying":"Common Stock","underlying_shares":5860},"source":{"system":"sec-edgar","filing":"0000899243-19-019303","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000089924319019303/doc4.xml","form_type":"4"}},{"id":3466370,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":66261,"kind":"person","name":"McCracken Joseph S","position":1,"cik":"0001632454","reported_name":"McCracken Joseph S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-07-08T20:05:19.000Z","date":"2019-07-05","kind":"exercise","acquired":false,"shares":2930,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option vested and became exercisable in twelve equal quarterly installments beginning on October 24, 2014."}],"balance_after":0,"derivative":{"exercise_price":0.82,"expiration_date":"2024-07-24","underlying":"Common Stock","underlying_shares":2930},"source":{"system":"sec-edgar","filing":"0000899243-19-019303","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000089924319019303/doc4.xml","form_type":"4"}},{"id":3466369,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":66261,"kind":"person","name":"McCracken Joseph S","position":1,"cik":"0001632454","reported_name":"McCracken Joseph S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-07-08T20:05:19.000Z","date":"2019-07-05","kind":"exercise","acquired":false,"shares":21682,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vested and became exercisable in twelve equal quarterly installments beginning on January 15, 2014."}],"balance_after":0,"derivative":{"exercise_price":0.82,"expiration_date":"2023-11-27","underlying":"Common Stock","underlying_shares":21682},"source":{"system":"sec-edgar","filing":"0000899243-19-019303","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000089924319019303/doc4.xml","form_type":"4"}},{"id":3466368,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":66261,"kind":"person","name":"McCracken Joseph S","position":1,"cik":"0001632454","reported_name":"McCracken Joseph S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-08T20:05:19.000Z","date":"2019-07-05","kind":"exercise","acquired":true,"shares":9034,"price":1.76,"value":15899.84,"ownership":{"direct":true},"balance_after":99372,"source":{"system":"sec-edgar","filing":"0000899243-19-019303","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000089924319019303/doc4.xml","form_type":"4"}},{"id":3466367,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":66261,"kind":"person","name":"McCracken Joseph S","position":1,"cik":"0001632454","reported_name":"McCracken Joseph S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-08T20:05:19.000Z","date":"2019-07-05","kind":"exercise","acquired":true,"shares":5860,"price":1.46,"value":8555.6,"ownership":{"direct":true},"balance_after":90338,"source":{"system":"sec-edgar","filing":"0000899243-19-019303","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000089924319019303/doc4.xml","form_type":"4"}},{"id":3466366,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":66261,"kind":"person","name":"McCracken Joseph S","position":1,"cik":"0001632454","reported_name":"McCracken Joseph S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-08T20:05:19.000Z","date":"2019-07-05","kind":"exercise","acquired":true,"shares":2930,"price":0.82,"value":2402.6,"ownership":{"direct":true},"balance_after":84478,"source":{"system":"sec-edgar","filing":"0000899243-19-019303","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000089924319019303/doc4.xml","form_type":"4"}},{"id":3466365,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":66261,"kind":"person","name":"McCracken Joseph S","position":1,"cik":"0001632454","reported_name":"McCracken Joseph S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-08T20:05:19.000Z","date":"2019-07-05","kind":"exercise","acquired":true,"shares":21682,"price":0.82,"value":17779.24,"ownership":{"direct":true},"balance_after":81548,"source":{"system":"sec-edgar","filing":"0000899243-19-019303","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000089924319019303/doc4.xml","form_type":"4"}},{"id":3674371,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":66261,"kind":"person","name":"McCracken Joseph S","position":1,"cik":"0001632454","reported_name":"McCracken Joseph S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-02-05T17:39:22.000Z","date":"2019-02-01","kind":"grant","acquired":true,"shares":48500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in four equal quarterly installments from the option grant date."}],"balance_after":48500,"derivative":{"exercise_price":9.91,"expiration_date":"2029-01-31","underlying":"Common Stock","underlying_shares":48500},"source":{"system":"sec-edgar","filing":"0001250853-19-000040","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1632454/000125085319000040/primary_doc.xml","form_type":"4"}},{"id":3730901,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":66261,"kind":"person","name":"McCracken Joseph S","position":1,"cik":"0001632454","reported_name":"McCracken Joseph S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-12-14T21:33:31.000Z","date":"2018-12-13","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest and become exercisable in twelve equal installments on each quarterly anniversary of December 13, 2018, subject to the reporting person's continued service with the Issuer."}],"balance_after":12000,"derivative":{"exercise_price":7.33,"expiration_date":"2028-12-13","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0000899243-18-031088","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000089924318031088/doc4.xml","form_type":"4"}},{"id":3883008,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":66261,"kind":"person","name":"McCracken Joseph S","position":1,"cik":"0001632454","reported_name":"McCracken Joseph S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-26T19:53:25.000Z","date":"2018-06-22","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in four equal quarterly installments following the grant date."}],"balance_after":10000,"derivative":{"exercise_price":11,"expiration_date":"2028-06-21","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001250853-18-000093","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1632454/000125085318000093/primary_doc.xml","form_type":"4"}},{"id":3958015,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":66261,"kind":"person","name":"McCracken Joseph S","position":1,"cik":"0001632454","reported_name":"McCracken Joseph S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-04-24T19:23:13.000Z","date":"2018-04-20","kind":"grant","acquired":true,"shares":41890,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in four quarterly installments following the grant date."}],"balance_after":41890,"derivative":{"exercise_price":9.65,"expiration_date":"2028-04-19","underlying":"Common Stock","underlying_shares":41890},"source":{"system":"sec-edgar","filing":"0001250853-18-000066","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1632454/000125085318000066/primary_doc.xml","form_type":"4"}},{"id":4126681,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":66261,"kind":"person","name":"McCracken Joseph S","position":1,"cik":"0001632454","reported_name":"McCracken Joseph S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-12-20T00:01:15.000Z","date":"2017-12-17","kind":"grant","acquired":true,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in six equal monthly installments on each monthly anniversary of December 17, 2017, subject to the reporting person's continued service with the Issuer."}],"balance_after":3750,"derivative":{"exercise_price":15.21,"expiration_date":"2027-12-17","underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0000899243-17-029244","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000089924317029244/doc4.xml","form_type":"4"}},{"id":4245745,"issuer":{"id":174046,"kind":"organization","name":"Nexvet Biopharma plc","symbol":"NVET"},"owners":[{"id":66261,"kind":"person","name":"McCracken Joseph S","position":1,"cik":"0001632454","reported_name":"McCracken Joseph S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2017-08-02T21:38:28.000Z","date":"2017-07-31","kind":"disposition_to_issuer","acquired":false,"shares":16400,"price":6.72,"value":110208.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed of pursuant to a transaction agreement between the Issuer, Zoetis Inc. (\"Zoetis\") and Zoetis Belgium S.A., a wholly-owned subsidiary of Zoetis (\"Bidco\"), pursuant to which Bidco acquired the Issuer."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001572426-17-000034","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1632454/000157242617000034/edgar.xml","form_type":"4"}},{"id":4264565,"issuer":{"id":174046,"kind":"organization","name":"Nexvet Biopharma plc","symbol":"NVET"},"owners":[{"id":66261,"kind":"person","name":"McCracken Joseph S","position":1,"cik":"0001632454","reported_name":"McCracken Joseph S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2017-07-05T12:59:13.000Z","date":"2017-07-01","kind":"exercise","acquired":false,"shares":3600,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0.125,"exercise_date":"2017-07-01","expiration_date":"2021-07-01","underlying":"Ordinary Shares","underlying_shares":3600},"source":{"system":"sec-edgar","filing":"0001171000-17-000047","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1632454/000117100017000047/edgar.xml","form_type":"4"}},{"id":4264564,"issuer":{"id":174046,"kind":"organization","name":"Nexvet Biopharma plc","symbol":"NVET"},"owners":[{"id":66261,"kind":"person","name":"McCracken Joseph S","position":1,"cik":"0001632454","reported_name":"McCracken Joseph S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2017-07-05T12:59:13.000Z","date":"2017-06-30","kind":"exercise","acquired":false,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0.125,"exercise_date":"2017-06-30","expiration_date":"2019-07-01","underlying":"Ordinary Shares","underlying_shares":500},"source":{"system":"sec-edgar","filing":"0001171000-17-000047","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1632454/000117100017000047/edgar.xml","form_type":"4"}},{"id":4264563,"issuer":{"id":174046,"kind":"organization","name":"Nexvet Biopharma plc","symbol":"NVET"},"owners":[{"id":66261,"kind":"person","name":"McCracken Joseph S","position":1,"cik":"0001632454","reported_name":"McCracken Joseph S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2017-07-05T12:59:13.000Z","date":"2017-07-01","kind":"exercise","acquired":true,"shares":3600,"price":0.125,"value":450.0,"ownership":{"direct":true},"balance_after":16400,"source":{"system":"sec-edgar","filing":"0001171000-17-000047","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1632454/000117100017000047/edgar.xml","form_type":"4"}},{"id":4264562,"issuer":{"id":174046,"kind":"organization","name":"Nexvet Biopharma plc","symbol":"NVET"},"owners":[{"id":66261,"kind":"person","name":"McCracken Joseph S","position":1,"cik":"0001632454","reported_name":"McCracken Joseph S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2017-07-05T12:59:13.000Z","date":"2017-06-30","kind":"exercise","acquired":true,"shares":500,"price":0.125,"value":62.5,"ownership":{"direct":true},"balance_after":12800,"source":{"system":"sec-edgar","filing":"0001171000-17-000047","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1632454/000117100017000047/edgar.xml","form_type":"4"}},{"id":4287202,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":66261,"kind":"person","name":"McCracken Joseph S","position":1,"cik":"0001632454","reported_name":"McCracken Joseph S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-09T14:30:28.000Z","date":"2017-06-07","kind":"purchase","acquired":true,"shares":52250,"price":4.75,"value":248187.5,"ownership":{"direct":true},"balance_after":59866,"source":{"system":"sec-edgar","filing":"0000899243-17-015868","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000089924317015868/doc4.xml","form_type":"4"}},{"id":4361450,"issuer":{"id":174046,"kind":"organization","name":"Nexvet Biopharma plc","symbol":"NVET"},"owners":[{"id":66261,"kind":"person","name":"McCracken Joseph S","position":1,"cik":"0001632454","reported_name":"McCracken Joseph S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2017-04-04T11:23:25.000Z","date":"2017-03-31","kind":"exercise","acquired":false,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"500 of the Restricted Share Units vested and became convertible on 3/31/17, and 500 Restricted Share Units shall vest and become convertible on 6/30/17, subject to payment of the nominal value per share to Issuer within 30 days of vesting."}],"balance_after":500,"derivative":{"exercise_price":0.125,"expiration_date":"2019-07-01","underlying":"Ordinary Shares","underlying_shares":500},"source":{"system":"sec-edgar","filing":"0001572426-17-000013","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1632454/000157242617000013/edgar.xml","form_type":"4"}},{"id":4361449,"issuer":{"id":174046,"kind":"organization","name":"Nexvet Biopharma plc","symbol":"NVET"},"owners":[{"id":66261,"kind":"person","name":"McCracken Joseph S","position":1,"cik":"0001632454","reported_name":"McCracken Joseph S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2017-04-04T11:23:25.000Z","date":"2017-03-31","kind":"exercise","acquired":true,"shares":500,"price":0.125,"value":62.5,"ownership":{"direct":true},"balance_after":12300,"source":{"system":"sec-edgar","filing":"0001572426-17-000013","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1632454/000157242617000013/edgar.xml","form_type":"4"}},{"id":4507958,"issuer":{"id":174046,"kind":"organization","name":"Nexvet Biopharma plc","symbol":"NVET"},"owners":[{"id":66261,"kind":"person","name":"McCracken Joseph S","position":1,"cik":"0001632454","reported_name":"McCracken Joseph S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2017-01-03T19:38:12.000Z","date":"2016-12-31","kind":"exercise","acquired":false,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"500 of the Restricted Share Units vested and became convertible on 12/31/16, and 500 Restricted Share Units shall vest and become convertible on each of 3/31/17 and 6/30/17, in each case subject to payment of the nominal value per share to Issuer within 30 days of vesting."}],"balance_after":1000,"derivative":{"exercise_price":0.125,"expiration_date":"2019-07-01","underlying":"Ordinary Shares","underlying_shares":500},"source":{"system":"sec-edgar","filing":"0001572426-17-000006","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1632454/000157242617000006/edgar.xml","form_type":"4"}},{"id":4507957,"issuer":{"id":174046,"kind":"organization","name":"Nexvet Biopharma plc","symbol":"NVET"},"owners":[{"id":66261,"kind":"person","name":"McCracken Joseph S","position":1,"cik":"0001632454","reported_name":"McCracken Joseph S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2017-01-03T19:38:12.000Z","date":"2016-12-31","kind":"exercise","acquired":true,"shares":500,"price":0.125,"value":62.5,"ownership":{"direct":true},"balance_after":11800,"source":{"system":"sec-edgar","filing":"0001572426-17-000006","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1632454/000157242617000006/edgar.xml","form_type":"4"}},{"id":4587041,"issuer":{"id":174046,"kind":"organization","name":"Nexvet Biopharma plc","symbol":"NVET"},"owners":[{"id":66261,"kind":"person","name":"McCracken Joseph S","position":1,"cik":"0001632454","reported_name":"McCracken Joseph S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2016-10-04T15:52:19.000Z","date":"2016-09-30","kind":"exercise","acquired":false,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"500 of the Restricted Share Units vested and became convertible on 9/30/16, and 500 Restricted Share Units shall vest and become convertible on each of 12/31/16, 3/31/17 and 6/30/17, in each case subject to payment of the nominal value per share to Issuer within 30 days of vesting."}],"balance_after":1500,"derivative":{"exercise_price":0.125,"expiration_date":"2019-07-01","underlying":"Ordinary Shares","underlying_shares":500},"source":{"system":"sec-edgar","filing":"0001572426-16-000238","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1632454/000157242616000238/edgar.xml","form_type":"4"}},{"id":4587040,"issuer":{"id":174046,"kind":"organization","name":"Nexvet Biopharma plc","symbol":"NVET"},"owners":[{"id":66261,"kind":"person","name":"McCracken Joseph S","position":1,"cik":"0001632454","reported_name":"McCracken Joseph S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2016-10-04T15:52:19.000Z","date":"2016-09-30","kind":"exercise","acquired":true,"shares":500,"price":0.125,"value":62.5,"ownership":{"direct":true},"balance_after":11300,"source":{"system":"sec-edgar","filing":"0001572426-16-000238","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1632454/000157242616000238/edgar.xml","form_type":"4"}},{"id":4609435,"issuer":{"id":174046,"kind":"organization","name":"Nexvet Biopharma plc","symbol":"NVET"},"owners":[{"id":66261,"kind":"person","name":"McCracken Joseph S","position":1,"cik":"0001632454","reported_name":"McCracken Joseph S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2016-09-07T17:49:24.000Z","date":"2016-09-05","kind":"exercise","acquired":true,"shares":3600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"3,600 of the Restricted Share Units shall vest and become convertible on 7/1/17, subject to payment of the nominal value per share to Issuer within 30 days of vesting."}],"balance_after":3600,"derivative":{"exercise_price":0.125,"exercise_date":"2017-07-01","expiration_date":"2021-07-01","underlying":"Ordinary Shares","underlying_shares":3600},"source":{"system":"sec-edgar","filing":"0001572426-16-000230","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1632454/000157242616000230/edgar.xml","form_type":"4"}}]}